Investigating the Requirement for Tbet Expression during Psoriasis
调查银屑病期间 Tbet 表达的要求
基本信息
- 批准号:7677176
- 负责人:
- 金额:$ 5.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAutoimmune ProcessCD4 Positive T LymphocytesCell physiologyCellsChronicColitisDataDevelopmentDiseaseExperimental Autoimmune EncephalomyelitisExperimental ModelsFeasibility StudiesImmune responseIndividualInflammationInflammatoryInterleukin-12Interleukin-13Interleukin-17Interleukin-4Interleukin-5MediatingMediator of activation proteinModelingMolecularMultiple SclerosisPathologyPatientsPopulationProductionPropertyPsoriasisResearchResearch DesignRheumatoid ArthritisRoleSTAT4 geneSignal TransductionSiteT-LymphocyteTh2 Cellsbasecytokinedesigninterleukin-22interleukin-23macrophagemouse modelnew therapeutic targetpathogenprogramsresponseskin disordertherapeutic targettranscription factor
项目摘要
For over a decade, a number of chronic inflammatory disorders including multiple sclerosis, rheumatoid
arthritis, and psoriasis have been described as Th1 -mediated disorders because IFNy-producing CD4 T cells
are prevalent in diseased patients and IFNy strongly activates macrophages, potentiating inflammation.
However recent data from animal models of numerous autoimmune/chronic inflammatory disorders suggests
that Th17 effector CD4 T cells are responsible for the induction of disease. Interestingly, the onset of these
chronic inflammatory diseases is associated with elevated numbers of both IFNy+ and IL-17+ effector CD4 T
cells at the sites of inflammation, opening the debate on the individual roles of these effector CD4 T cell
populations during disease. In fact, the impact of Th1 CD4 T cells on the development of psoriasis remains
unclear. Under certain experimental conditions, psoriasis can be induced by IL-12 stimulation and this
pathology is associated with increased levels of IFNy, although it has been demonstrated that IFNy is not
essential to drive disease. The Th1-associated transcription factors Tbet and STAT4 are required to induce
some experimental models of chronic inflammation, such as EAE and colitis, even when IFNy is not. To
date, little is known about the role of these transcriptional regulators during the development of psoriasis.
We hypothesize that Tbet and STAT4, Th1-associated transcription factors, are necessary for the
development of psoriasis mediated by CD4 T cells. We propose the following specific aims to determine
the role of Tbet and STAT4 during two models of psoriasis mediated by distinct effector mechanisms.
Aim 1. Tbet is required for the development of psoriasis.
Aim 2. STAT4 signaling is critical for the onset of psoriasis.
Collectively, these studies are designed to provide new information regarding the molecular mechanisms of
CD4 T cell-mediated psoriasis. The findings from these studies may identify new potential targets for
therapeutic and/or preventative strategies designed to ablate psoriasis, as well as other chronic inflammatory
disorders.
十多年来,许多慢性炎症性疾病,包括多发性硬化症,类风湿病
关节炎和牛皮癣已被描述为Th1介导的疾病,因为产生的CD4 T细胞
患病患者普遍存在,IFNY强烈激活巨噬细胞,增强炎症。
但是,来自众多自身免疫/慢性炎症性疾病的动物模型的最新数据表明
Th17效应子CD4 T细胞负责诱导疾病。有趣的是,这些发作
慢性炎症性疾病与IFNY+和IL-17+效应的CD4 T的数量增加有关
炎症部位的细胞,就这些效应子CD4 T细胞的各个角色的辩论开放
疾病期间的种群。实际上,Th1 CD4 T细胞对牛皮癣发展的影响仍然存在
不清楚。在某些实验条件下,牛皮癣可以通过IL-12刺激诱导,这
病理学与IFNY水平升高有关,尽管已经证明IFNY不是
驱动疾病必不可少的。需要Th1相关的转录因子TBET和STAT4才能诱导
即使不是IFNY,一些慢性炎症的实验模型,例如EAE和结肠炎。到
日期,对于这些转录调节剂在牛皮癣发展过程中的作用知之甚少。
我们假设TBET和STAT4,Th1相关的转录因子是必要的
CD4 T细胞介导的牛皮癣的发展。我们提出以下具体目的来确定
TBET和STAT4在由不同的效应器机制介导的两种牛皮癣模型中的作用。
目的1。TBET是牛皮癣发展所必需的。
AIM2。STAT4信号对于牛皮癣的发作至关重要。
总的来说,这些研究旨在提供有关分子机制的新信息
CD4 T细胞介导的牛皮癣。这些研究的发现可能会确定
旨在消除牛皮癣的治疗和/或预防性策略以及其他慢性炎症
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURIE E HARRINGTON其他文献
LAURIE E HARRINGTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Setd2通过调控糖酵解过程促进树突状细胞活化启动1型糖尿病自身免疫应答的机制研究
- 批准号:82300929
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态对比增强联合分子靶向MRI可视化自身免疫性周围神经损伤及修复过程的实验研究
- 批准号:82302173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α-心脏肌球蛋白重链特异性T细胞在自身免疫性心肌炎致病过程中的作用及机制探讨
- 批准号:82000470
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
LC3相关的吞噬作用(LAP)对矽肺发展过程中矽尘诱发自身免疫性疾病的作用机制研究
- 批准号:81773376
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
自身免疫性胆管炎发病过程中NK细胞的免疫调节作用
- 批准号:81401336
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel Inhibitors for Temporal Modulation of T-Lymphocytes during Chronic Heart Failure
慢性心力衰竭期间 T 淋巴细胞时间调节的新型抑制剂
- 批准号:
10638340 - 财政年份:2023
- 资助金额:
$ 5.41万 - 项目类别:
Biophysical parameters of self-reactive TCR engagement in T1D
T1D 中自反应 TCR 参与的生物物理参数
- 批准号:
10681917 - 财政年份:2023
- 资助金额:
$ 5.41万 - 项目类别:
Immunological Basis of Autoimmune Addison's Disease in a Novel Canine Model System
新型犬模型系统中自身免疫阿狄森氏病的免疫学基础
- 批准号:
10830527 - 财政年份:2023
- 资助金额:
$ 5.41万 - 项目类别:
Role of apoE in HDL-mediated enhanced survival of human regulatory T-cells
apoE 在 HDL 介导的人类调节性 T 细胞存活增强中的作用
- 批准号:
10577476 - 财政年份:2023
- 资助金额:
$ 5.41万 - 项目类别:
Polymer-derived biomaterials for mRNA delivery to induce antigen-specific immune tolerance
用于 mRNA 递送以诱导抗原特异性免疫耐受的聚合物衍生生物材料
- 批准号:
10886168 - 财政年份:2023
- 资助金额:
$ 5.41万 - 项目类别: